Literature DB >> 8515827

Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results.

P Anderer1, M J Barbanoj, B Saletu, H V Semlitsch.   

Abstract

The number and types of target variables quantified from the spectrally analyzed EEG used in topographic pharmaco-EEG studies are still being discussed. Drug-induced changes of target variables obtained in the alpha frequency band--four absolute and four relative powers as well as three frequency measures--were utilized to assess the effects of xantinolnicotinate in demented patients using a parallel group design and the effects of buspirone in a double-blind, placebo-controlled crossover design. We conclude that for the proper evaluation of the different drug effects on the alpha activity, all these target variables should be considered. Descriptive p values of multiple comparisons within the framework of descriptive data analyses are important tools in interpreting drug effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8515827     DOI: 10.1159/000118963

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  3 in total

1.  Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).

Authors:  B Saletu; P Anderer; G M Saletu-Zyhlarz; D Gruber; M Metka; J Huber
Journal:  Psychopharmacology (Berl)       Date:  2004-11-03       Impact factor: 4.530

2.  EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

Authors:  R H McAllister-Williams; A E Massey
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

Review 3.  Quantitative Pharmaco-Electroencephalography in Antiepileptic Drug Research.

Authors:  Yvonne Höller; Christoph Helmstaedter; Klaus Lehnertz
Journal:  CNS Drugs       Date:  2018-09       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.